持续质量改进对弥漫大B细胞淋巴瘤化疗管理质量及患者消化道不良反应的影响  

作　　者：吴瑛[1] 薛登梅[1] 游炳丽 

机构地区：[1]成都市第六人民医院,四川成都610051

出　　处：《现代消化及介入诊疗》2018年第A02期270-271,共2页Modern Interventional Diagnosis and Treatment in Gastroenterology

摘　　要：目的:探讨持续质量改进对弥漫大B细胞淋巴瘤化疗管理质量及患者消化道不良反应的影响。方法:选取我院收治的弥漫大B细胞淋巴瘤患者184例作为研究对象,按照就诊顺序分成实验组(实施持续质量改进护理模式)和对照组(实施传统护理模式),对比两组护理效果及不良反应发生情况。结果:实验组患者护理效果明显优于对照组,其消化道不良反应发生率及程度均优于对照组,两组结果具有比较的意义。结论:实施持续质量改进护理模式能够提高弥漫大B细胞淋巴瘤化疗过程中护理质量,降低不良反应发生率。Objective:To investigate the effects of continuous quality improvement of diffuse large B-cell lymphoma with chemotherapy and quality management of patients with gastrointestinal adverse reactions.Method:Admitted to our hospital patients with diffuse large B-cell lymphoma 184 cases as research subjects,according to the order of treatment divided into experimental group(the implementation of continuous quality improvement model of care)and control group(traditional implementation model of care),compared two groups of nursing effects and adverse events.Result:Care patients in the experimental group is better than the control group,the incidence of gastrointestinal adverse reactions and degree than the control group,two sets of results meaningful comparison.Conclusion:The implementation of continuous quality improvement model of care can improve diffuse large B-cell lymphoma chemotherapy quality of care,reduce the incidence of adverse reactions.

关 键 词：淋巴瘤 化疗管理质量 不良反应 

分 类 号：R733[医药卫生—肿瘤]